Chris Wallace

Chris Wallace

Auto-generated profile, based on publicly available information

Chris Wallace

MRC Biostatistics Unit, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2014 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
CGClaudia Giambartolomei
Claudia Giambartolomei
DVDamjan Vukcevic
Damjan Vukcevic
ESEric E Schadt
Eric E Schadt
LFLude Franke
Lude Franke
AHAroon D Hingorani
Aroon D Hingorani
VPVincent Plagnol
Vincent Plagnol
Genetic association studies, in particular the genome-wide association study (GWAS) design, have provided a wealth of novel insights into the aetiology of a wide range of human diseases and traits, in particular cardiovascular diseases and lipid biomarkers. The next challenge consists of understanding the molecular basis of these associations. The integration of multiple association datasets, including gene expression datasets, can contribute to this goal. We have developed a novel statistical methodology to assess whether two association signals are consistent with a shared causal variant. An application is the integration of disease scans with expression quantitative trait locus (eQTL) studies, but any pair of GWAS datasets can be integrated in this framework. We demonstrate the value of the approach by re-analysing a gene expression dataset in 966 liver samples with a published meta-analysis of lipid traits including >100,000 individuals of European ancestry. Combining all lipid biomarkers, our re-analysis supported 26 out of 38 reported colocalisation results with eQTLs and identified 14 new colocalisation results, hence highlighting the value of a formal statistical test. In three cases of reported eQTL-lipid pairs (SYPL2, IFT172, TBKBP1) for which our analysis suggests that the eQTL pattern is not consistent with the lipid association, we identify alternative colocalisation results with SORT1, GCKR, and KPNB1, indicating that these genes are more likely to be causal in these genomic intervals. A key feature of the method is the ability to derive the output statistics from single SNP summary statistics, hence making it possible to perform systematic meta-analysis type comparisons across multiple GWAS datasets (implemented online at http://coloc.cs.ucl.ac.uk/coloc/). Our methodology provides information about candidate causal genes in associated intervals and has direct implications for the understanding of complex diseases as well as the design of drugs to target disease pathways. Genome-wide association studies (GWAS) have found a large number of genetic regions (“loci”) affecting clinical end-points and phenotypes, many outside coding intervals. One approach to understanding the biological basis of these associations has been to explore whether GWAS signals from intermediate cellular phenotypes, in particular gene expression, are located in the same loci (“colocalise”) and are potentially mediating the disease signals. However, it is not clear how to assess whether the same variants are responsible for the two GWAS signals or whether it is distinct causal variants close to each other. In this paper, we describe a statistical method that can use simply single variant summary statistics to test for colocalisation of GWAS signals. We describe one application of our method to a meta-analysis of blood lipids and liver expression, although any two datasets resulting from association studies can be used. Our method is able to detect the subset of GWAS signals explained by regulatory effects and identify candidate genes affected by the same GWAS variants. As summary GWAS data are increasingly available, applications of colocalisation methods to integrate the findings will be essential for functional follow-up, and will also be particularly useful to identify tissue specific signals in eQTL datasets.

6 June 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JTJohn A Todd
John A Todd
NWNeil M Walker
Neil M Walker
JCJason D Cooper
Jason D Cooper
DSDeborah J Smyth
Deborah J Smyth
KDKate Downes
Kate Downes
DCDavid G Clayton
David G Clayton

4 May 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
RLRuth J F Loos
Ruth J F Loos
CLCecilia Lindgren
Cecilia Lindgren
SLShengxu Li
Shengxu Li
EWEleanor Wheeler
Eleanor Wheeler
JZJing Hua Zhao
Jing Hua Zhao
KMKaren L Mohlke
Karen L Mohlke

1 November 2016 in Cell
Verified
Journal Article
Open access
Biola M. JavierreBiola M. Javierre
Biola M. Javierre
OBOliver S. Burren
Oliver S. Burren
SWSteven P. Wilder
Steven P. Wilder
RKRoman Kreuzhuber
Roman Kreuzhuber
SHSteven M. Hill
Steven M. Hill
PFPeter Fraser
Peter Fraser
Long-range interactions between regulatory elements and gene promoters play key roles in transcriptional regulation. The vast majority of interactions are uncharted, constituting a major missing link in understanding genome control. Here, we use promoter capture Hi-C to identify interacting regions of 31,253 promoters in 17 human primary hematopoietic cell types. We show that promoter interactions are highly cell type specific and enriched for links between active promoters and epigenetically marked enhancers. Promoter interactomes reflect lineage relationships of the hematopoietic tree, consistent with dynamic remodeling of nuclear architecture during differentiation. Interacting regions are enriched in genetic variants linked with altered expression of genes they contact, highlighting their functional role. We exploit this rich resource to connect non-coding disease variants to putative target promoters, prioritizing thousands of disease-candidate genes and implicating disease pathways. Our results demonstrate the power of primary cell promoter interactomes to reveal insights into genomic regulatory mechanisms underlying common diseases.

10 May 2009 in Nature Genetics
Verified
Journal Article
Open access
PDF file
WCWellcome Trust Case Control Consortium
Wellcome Trust Case Control Consortium
CNChristopher Newton-Cheh
Christopher Newton-Cheh
TJToby Johnson
Toby Johnson
VGVesela Gateva
Vesela Gateva
MTMartin D Tobin
Martin D Tobin
PMPatricia B Munroe
Patricia B Munroe
Christopher Newton-Cheh and colleagues report a genome-wide association study for blood pressure traits as part of the Global BPgen consortium. They report eight loci with replicated association to systolic and/or diastolic blood pressure, with each also showing association to hypertension. Elevated blood pressure is a common, heritable cause of cardiovascular disease worldwide. To date, identification of common genetic variants influencing blood pressure has proven challenging. We tested 2.5 million genotyped and imputed SNPs for association with systolic and diastolic blood pressure in 34,433 subjects of European ancestry from the Global BPgen consortium and followed up findings with direct genotyping (N ≤ 71,225 European ancestry, N ≤ 12,889 Indian Asian ancestry) and in silico comparison (CHARGE consortium, N = 29,136). We identified association between systolic or diastolic blood pressure and common variants in eight regions near the CYP17A1 (P = 7 × 10−24), CYP1A2 (P = 1 × 10−23), FGF5 (P = 1 × 10−21), SH2B3 (P = 3 × 10−18), MTHFR (P = 2 × 10−13), c10orf107 (P = 1 × 10−9), ZNF652 (P = 5 × 10−9) and PLCD3 (P = 1 × 10−8) genes. All variants associated with continuous blood pressure were associated with dichotomous hypertension. These associations between common variants and blood pressure and hypertension offer mechanistic insights into the regulation of blood pressure and may point to novel targets for interventions to prevent cardiovascular disease.

6 November 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
S(Spanish Consortium on the Genetics of Coeliac Disease (CEGEC)
Spanish Consortium on the Genetics of Coeliac Disease (CEGEC)
GTGosia Trynka
Gosia Trynka
PGPreventCD Study Group
PreventCD Study Group
W(Wellcome Trust Case Control Consortium (WTCCC)
Wellcome Trust Case Control Consortium (WTCCC)
KHKaren A Hunt
Karen A Hunt
DHDavid A van Heel
David A van Heel
David van Heel, Cisca Wijmenga and colleagues used a custom, high-density genotyping chip to examine 183 immune-related loci for their role in celiac disease. They report 13 new regions associated with celiac disease risk, identify multiple independent signals at several loci and refine the localization of many previously reported risk signals. Using variants from the 1000 Genomes Project pilot European CEU dataset and data from additional resequencing studies, we densely genotyped 183 non-HLA risk loci previously associated with immune-mediated diseases in 12,041 individuals with celiac disease (cases) and 12,228 controls. We identified 13 new celiac disease risk loci reaching genome-wide significance, bringing the number of known loci (including the HLA locus) to 40. We found multiple independent association signals at over one-third of these loci, a finding that is attributable to a combination of common, low-frequency and rare genetic variants. Compared to previously available data such as those from HapMap3, our dense genotyping in a large sample collection provided a higher resolution of the pattern of linkage disequilibrium and suggested localization of many signals to finer scale regions. In particular, 29 of the 54 fine-mapped signals seemed to be localized to single genes and, in some instances, to gene regulatory elements. Altogether, we define the complex genetic architecture of the risk regions of and refine the risk signals for celiac disease, providing the next step toward uncovering the causal mechanisms of the disease.